Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6288051

Cc1[nH]c2ccccc2c1CC(=O)N[C@H](Cc1ccncc1)C(=O)Nc1ccc(C(c2ccc(NC(=O)[C@@H](Cc3ccncc3)NC(=O)Cc3c(C)[nH]c4ccccc34)cc2)c2ccc(NC(=O)[C@@H](Cc3ccncc3)NC(=O)Cc3c(C)[nH]c4ccccc34)cc2)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 6/20 0.44
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
CASP1 P29466 1/20 0.40
CASP7 P55210 1/20 0.40
S1PR1 P21453 1/20 0.40
KLK6 Q92876 2/20 0.40
PRSS1 P07477 1/20 0.39
PRSS2 P07478 1/20 0.39
PRSS3 P35030 1/20 0.39
EGFR P00533 1/20 0.39
SRC P12931 1/20 0.39
NPY5R Q15761 1/20 0.39
FNTA P49354 1/20 0.39
FNTB P49356 1/20 0.39
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6285408 0.90 HDAC1 (0.44) HDAC1KDM4EALDH1A1GAAMAPT
SCHEMBL6286718 0.90 HDAC1 (0.50) HDAC1KDM4EALDH1A1GAAMAPT
Trifluoroacetic Acid SCHEMBL6290995 0.89 HDAC1 (0.54) HDAC1HDAC3HDAC4HDAC7HDAC2
Trifluoroacetic Acid SCHEMBL6356125 0.89 HDAC1 (0.43) HDAC1KDM4EALDH1A1GAAMAPT
Trifluoroacetic Acid SCHEMBL6290559 0.88 HDAC1 (0.47) HDAC1KDM4EALDH1A1GAAMAPT
Trifluoroacetic Acid SCHEMBL6290833 0.86 HDAC1 (0.49) HDAC1KDM4EALDH1A1GAAMAPT
SCHEMBL6287018 0.86 ESR1 (0.48) HDAC1KDM4EALDH1A1GAAMAPT
Trifluoroacetic Acid SCHEMBL6287362 0.84 LMNA (0.49) HDAC1MAPTHDAC3HDAC4HDAC7
SCHEMBL6290249 0.83 HDAC8 (0.50) HDAC1S1PR1HDAC3HDAC4HDAC7
SCHEMBL6287571 0.82 HDAC1 (0.43) HDAC1GAAMAPTHDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6887890-B2 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2005-05-03 US disclosed
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-08-28 US disclosed
EP-1291341-A1 COMPOUNDS EXHIBITING THROMBOPOIETIN-LIKE ACTIVITIES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-03-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities MPL, THPO, TEK HDAC1 3488/4885KDM4E 2972/4885ALDH1A1 2042/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.